Capgemini announced a new generative AI-driven methodology for protein engineering that uses a specialized protein large language model (pLLM) to predict the most effective protein variants. With a patent pending, this novel approach will help accelerate the advancement of the global bioeconomy and drive critical scientific breakthroughs across industries...
With the goal of streamlining industry-wide clinical trial recruitment and improving patient outcomes, myTomorrows unveils its next major AI-powered technological advancement.
myTomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, announced the launch of its next-generation AI platform. Designed to streamline clinical trial...
Inspire, the leading patient network and real-world evidence solutions provider, announced the launch of Patient Voice AI, a groundbreaking product designed to revolutionize how life sciences organizations gather and leverage patient insights. Built on Inspire’s unique dataset of over 12 million authentic patient and caregiver discussions, Patient Voice AI...
Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility - PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and Less Than 2 hrs for FASTQ Files
BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the...
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced it has entered a strategic partnership with Alimentiv Inc., a global GI (gastrointestinal) contract research organization (CRO), to support the optimal design and execution of advanced adaptive clinical trials for a range of GI conditions....
Company’s AI approach identifies hidden cancers years before symptoms appear and spares low-risk patients from unnecessary procedures
C the Signs, the creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, announced $8 million in funding from Khosla Ventures....
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical trial development
Cognizant announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata's life sciences clients and...
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
OSE Immunotherapeutics SA and Scienta Lab, a leader in Artificial Intelligence (AI)-driven precision immunology, announce a strategic collaboration to harness Scienta Lab’s advanced AI platform for modeling inflammatory diseases and identifying predictive biomarkers of efficacy...
New Capabilities aim to strengthen corporate profile for strategic transactions and reinforce ongoing partnering discussions
TME Pharma N.V., a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced a collaboration with aimed analytics, a cutting-edge medical data analytics company. This...
AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and development, announced the continuation and expansion of its collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin), a Japan-based global specialty pharmaceutical company. The enhanced partnership...
